Literature DB >> 6862845

Value of spirometric investigations in amyotrophic lateral sclerosis.

M Poloni, S A Mento, C Mascherpa, M Ceroni.   

Abstract

The respiratory function has been studied in 37 patients with ALS. 15 of them (5 till death) were followed with serial spirometric tests. The data, as a whole, show a diminution of vital capacity, a diminution of forced expiratory volume per second, an increase of the residual volume and of the Motley index; blood gas analysis showed no significant alterations apart from slight hypoxemia. Patients with bulbar ALS presented marked abnormalities of the spirometric and blood gas analysis parameters. In the cases followed with serial spirometric tests VC, Motley index and FEV1 gradually deteriorated as the disease advanced. In the deceased patients a sudden and serious aggravation of these values occurred. This was especially true for FEV1 and Motley index during the 3 months preceding death. The variations in residual volume were less indicative. Finally, the influence of smoking and of pulmonary and bronchial pathology, present or past, was not significant.

Entities:  

Mesh:

Year:  1983        PMID: 6862845     DOI: 10.1007/bf02043436

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  11 in total

1.  THE EFFECT OF RESPIRATORY MUSCLE DYSFUNCTION ON PULMONARY FUNCTION. STUDIES IN PATIENTS WITH SPINAL CORD INJURIES.

Authors:  D J STONE; H KELTZ
Journal:  Am Rev Respir Dis       Date:  1963-11

2.  THE EFFECT OF RESPIRATORY MUSCLE DYSFUNCTION ON PULMONARY FUNCTION: STUDIES IN PATIENTS WITH NEUROMUSCULAR DISEASE.

Authors:  H KELTZ
Journal:  Am Rev Respir Dis       Date:  1965-06

3.  Amyotrophic lateral sclerosis: a study of pulmonary function.

Authors:  K K Nakano; H Bass; H R Tyler; R J Carmel
Journal:  Dis Nerv Syst       Date:  1976-01

4.  [Amyotrophic lateral sclerosis and paralysis of dilatators of the glottis].

Authors:  T ALAJOUANINE; M BOUCHET; P PIALOUX; F LHERMITTE
Journal:  Ann Otolaryngol       Date:  1953

5.  The administration of guanidine in amyotrophic lateral sclerosis.

Authors:  F H Norris; P R Calanchini; R J Fallat; S Panchari; B Jewett
Journal:  Neurology       Date:  1974-08       Impact factor: 9.910

6.  Prognosis of amyotrophic lateral sclerosis.

Authors:  K Boman; T Meurman
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

7.  Respiratory muscle function in amyotrophic lateral sclerosis.

Authors:  S M Kreitzer; N A Saunders; H R Tyler; R H Ingram
Journal:  Am Rev Respir Dis       Date:  1978-03

8.  Spirometry in amyotrophic lateral sclerosis.

Authors:  R J Fallat; B Jewitt; M Bass; B Kamm; F H Norris
Journal:  Arch Neurol       Date:  1979-02

9.  Exertional dyspnea: a primary complaint in unusual cases of progressive muscular atrophy and amyotrophic lateral sclerosis.

Authors:  W S FOWLER; R D MILLER; D W MULDER; A M OLSEN
Journal:  Ann Intern Med       Date:  1957-01       Impact factor: 25.391

10.  Management of hypoventilation in motor neuron disease presenting with respiratory insufficiency.

Authors:  E D Sivak; E W Streib
Journal:  Ann Neurol       Date:  1980-02       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.